Paclitaxel-related hypersensitivity reactions and monitoring recommendations.
Myers
Jamie S
JS
Cancer Institute-Meyer Campus, Kansas City, MO, USA. jsmyers@healthmidwest.org
D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects* / Q000276:immunology / Q000627:therapeutic use; D004342:Drug Hypersensitivity / Q000451:nursing* / Q000503:physiopathology*; D006801:Humans; D008991:Monitoring, Physiologic; D017239:Paclitaxel / Q000009:adverse effects* / Q000276:immunology / Q000627:therapeutic use
D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel